Ranbaxy shares plunge 3% on US recall

Shares of Ranbaxy today slumped over three per cent on the bourses after the company said it has recalled its cholesterol-lowering drug Atorvastatin, a generic version of Pfizer Inc's Lipitor, from the US market.

"The company has made a recall of Atorvastatin from the USA market which will cause temporary disruption to that market of this product," the company said in a statement.

Reacting to the news, shares of the company tanked 4.18 per cent to an intra-day low of Rs 491.25 on the BSE. The company however, recovered some lost ground and settled for the day at Rs 495.95, lower by 3.27 per cent from its previous closing price.

Following the slump in the share price, the market capitalisation of the company shrunk by Rs 410 crore to Rs 20,952 crore, in just a single trading session. The market worth of the company stood at Rs 21,362 crore yesterday.

"The investigation with regard to the same of this issue is expected to be completed within two weeks and thereafter the Company expects to resume supplies," the company release said.

Meanwhile, on the National Stock Exchange as well, the stock witnessed similar movement. It opened at Rs 513.15, then fell to an intra-day low of Rs 490.70. The stock finally ended the day at Rs 495.85, lower by 3.28 per cent from its last close.

Stocks More on Ranbaxy

Company INFO More on Ranbaxy

Please read our terms of use before posting comments
TERMS OF USE: The views expressed in comments published on indianexpress.com are those of the comment writer's alone. They do not represent the views or opinions of The Indian Express Group or its staff. Comments are automatically posted live; however, indianexpress.com reserves the right to take it down at any time. We also reserve the right not to publish comments that are abusive, obscene, inflammatory, derogatory or defamatory.